Research & Development
At Abseil Pharma, we're pioneering the future of medicine through cutting-edge research and innovative drug development. Our commitment to scientific excellence drives our mission to address unmet medical needs.
At Abseil Pharma, we're pioneering the future of medicine through cutting-edge research and innovative drug development. Our commitment to scientific excellence drives our mission to address unmet medical needs.
Targeting innovative solutions for pressing healthcare challenges
Developing novel therapies for asthma, COPD, and other respiratory conditions with improved efficacy and safety profiles.
Learn MorePioneering targeted cancer therapies and immunotherapies that offer new hope for patients with difficult-to-treat cancers.
Learn MoreAdvancing treatments for neurological disorders including Alzheimer's, Parkinson's, epilepsy, and neuropathic pain.
Learn MoreInnovating next-generation cardiovascular drugs for hypertension, heart failure, and metabolic disorders.
Learn MoreDeveloping novel antimicrobials and antiviral agents to address emerging infectious disease threats and antimicrobial resistance.
Learn MoreCreating advanced drug delivery systems that improve bioavailability, targeting, and patient compliance.
Learn MoreFrom discovery to development - our comprehensive approach to pharmaceutical innovation
Identifying novel biological targets for therapeutic intervention
Screening and optimizing compounds with therapeutic potential
Testing candidate compounds in laboratory and animal models
Conducting human trials to evaluate safety and efficacy
Submitting data to health authorities for marketing approval
Quantifying our commitment to pharmaceutical innovation
Contributing to scientific knowledge through peer-reviewed research
Journal of Medicinal Chemistry, 2023
This study describes the discovery and characterization of a new class of phosphodiesterase-4 inhibitors with improved safety profiles for chronic obstructive pulmonary disease.
Read PublicationNature Nanotechnology, 2023
Our team developed a novel nanoparticle-based drug delivery system that specifically targets tumor cells while minimizing exposure to healthy tissues, demonstrating significantly reduced side effects.
Read PublicationScience Translational Medicine, 2023
We present an artificial intelligence platform that accelerates the identification of potential therapeutics for rare genetic disorders, with promising results for Niemann-Pick disease type C.
Read PublicationThe Lancet HIV, 2023
This clinical study demonstrates the efficacy and safety of our novel long-acting injectable antiretroviral therapy, which could transform HIV treatment by reducing dosing frequency from daily to monthly.
Read PublicationWorld-class infrastructure enabling cutting-edge pharmaceutical research
Equipped with cutting-edge instrumentation for compound characterization and analysis.
State-of-the-art facilities for genomics, proteomics, and cellular research.
Automated systems capable of screening millions of compounds for biological activity.
Advanced computing resources for molecular modeling, AI, and data analysis.
Collaborating with leading institutions to advance pharmaceutical science
Join us in our mission to transform patient care through innovative pharmaceutical research and development.